companies / renasantbio-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
Renasant Bio, Inc. was listed in Atlas Venture's portfolio, recorded 2026-09-30.
verified=2026-10-03 json
| total_raised | 55,461,18455.5M | D |
|---|---|---|
| founded | null | |
| hq | BERKELEY, CA | |
| industry | unknown | |
| stage | null |
Renasant Bio develops small-molecule correctors and potentiators that restore polycystin proteins damaged in autosomal dominant polycystic kidney disease. It targets the roughly 12 million people with ADPKD, a genetic cause of kidney failure. Its molecules work across a broad range of mutations, none affecting more than about 2% of patients.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-07-14 | Funding round | 30,000,00030.0M | null | D |
| 2024-07-15 | Funding round | 25,461,18425.5M | null | D |
| person | role | src |
|---|---|---|
| Anna French | director | D |
| Charlotte McKee | director | D |
| Deborah Palestrant | director | D |
| Emily Conley | director | D |
| Emily Conley | executive | D |
| Evan Caplan | director | D |
| June Lee | director | D |
| Kevin Bitterman |
| investor | src |
|---|---|
| Atlas Venture | ○ |
Google Cloud CDN, Sentry, Vercel Speed Insights, WebsiteBuilder, Wix, Google Cloud, React, lodash .
| fact | status | src |
|---|---|---|
| Funding round, $30.0M | sourced | D |
| Funding round, $25.5M | sourced | D |
| Investor Atlas Venture | sourced | WEB |
| existence | sourced | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-10-03provenance_existence: self-reported → sourced, WEB 2026-10-03 | provenance_existence | self-reported → sourced | WEB 2026-10-03 |
| 2026-09-30provenance_investor_atlas_venture: unknown → sourced, WEB 2026-09-30 | provenance_investor_atlas_venture | unknown → sourced | WEB 2026-09-30 |
| 2026-09-28total_raised: 30000000 → 55461184, D 2026-09-25 | total_raised | 30000000 → 55461184 |
| director |
| D |
| Natalie Holles | director | D |
| Thomas Gustafson | executive | D |
| 2026-09-25latest_round: seed, $30.0M, 2025-07-14 → Funding round, $30.0M, 2025-07-14, D 2026-09-25 | latest_round | seed, $30.0M, 2025-07-14 → Funding round, $30.0M, 2025-07-14 | D 2026-09-25 |
| 2026-09-25provenance_round: attributed → sourced, D 2026-09-25 | provenance_round | attributed → sourced | D 2026-09-25 |
Records begin 2026-09-24. all_changes